文/张向东海外授权交易金额845亿美元，占全球交易量33%。恒生医疗保健指数年内涨幅达100.7%，恒生港股通创新药指数涨幅近115.9%。港股医疗保健行业通过IPO募资金额超过过去3年全年总和。仅9月以来，就有超12家药企向港交所递交IPO申请。截至2025年10月23日，港交所正在处理的上市申请约300家，其中半数为新经济领域企业，涵盖人工智能、生物技术等行业。这是2025年前十个月，中国...
Source Link文/张向东海外授权交易金额845亿美元，占全球交易量33%。恒生医疗保健指数年内涨幅达100.7%，恒生港股通创新药指数涨幅近115.9%。港股医疗保健行业通过IPO募资金额超过过去3年全年总和。仅9月以来，就有超12家药企向港交所递交IPO申请。截至2025年10月23日，港交所正在处理的上市申请约300家，其中半数为新经济领域企业，涵盖人工智能、生物技术等行业。这是2025年前十个月，中国...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.